Literature DB >> 22340596

Tumorigenic cells are common in mouse MPNSTs but their frequency depends upon tumor genotype and assay conditions.

Johanna Buchstaller1, Paul E McKeever, Sean J Morrison.   

Abstract

Tumor-initiating cells have been suggested to be rare in many cancers. We tested this in mouse malignant peripheral nerve sheath tumors (MPNSTs) and found that 18% of primary and 49% of passaged MPNST cells from Nf1(+/-); Ink4a/Arf(-/-) mice formed tumors upon transplantation, whereas only 1.8% to 2.6% of MPNST cells from Nf1(+/-); p53(+/-) mice did. MPNST cells of both genotypes require laminin binding to β1-integrin for clonogenic growth. Most MPNST cells from Nf1(+/-); Ink4a/Arf(-/-) mice expressed laminin, whereas most MPNST cells from Nf1(+/-); p53(+/-) mice did not. Exogenous laminin increased the percentage of MPNST cells from Nf1(+/-); p53(+/-) but not Nf1(+/-); Ink4a/Arf(-/-) mice that formed tumorigenic colonies. Tumor-forming potential is common among MPNST cells, but the assay conditions required to detect it vary with tumor genotype. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22340596      PMCID: PMC3285409          DOI: 10.1016/j.ccr.2011.12.027

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  53 in total

Review 1.  Applying the principles of stem-cell biology to cancer.

Authors:  Ricardo Pardal; Michael F Clarke; Sean J Morrison
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

2.  Mouse tumor model for neurofibromatosis type 1.

Authors:  K S Vogel; L J Klesse; S Velasco-Miguel; K Meyers; E J Rushing; L F Parada
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

3.  Specific functions for ERK/MAPK signaling during PNS development.

Authors:  Jason M Newbern; Xiaoyan Li; Sarah E Shoemaker; Jiang Zhou; Jian Zhong; Yaohong Wu; Daniel Bonder; Steven Hollenback; Giovanni Coppola; Daniel H Geschwind; Gary E Landreth; William D Snider
Journal:  Neuron       Date:  2011-01-13       Impact factor: 17.173

Review 4.  Matrigel: basement membrane matrix with biological activity.

Authors:  Hynda K Kleinman; George R Martin
Journal:  Semin Cancer Biol       Date:  2005-10       Impact factor: 15.707

Review 5.  Integrin signalling during tumour progression.

Authors:  Wenjun Guo; Filippo G Giancotti
Journal:  Nat Rev Mol Cell Biol       Date:  2004-10       Impact factor: 94.444

6.  Tumour predisposition in mice heterozygous for a targeted mutation in Nf1.

Authors:  T Jacks; T S Shih; E M Schmitt; R T Bronson; A Bernards; R A Weinberg
Journal:  Nat Genet       Date:  1994-07       Impact factor: 38.330

7.  Tumor growth need not be driven by rare cancer stem cells.

Authors:  Priscilla N Kelly; Aleksandar Dakic; Jerry M Adams; Stephen L Nutt; Andreas Strasser
Journal:  Science       Date:  2007-07-20       Impact factor: 47.728

8.  Characterization of melanoma cells capable of propagating tumors from a single cell.

Authors:  Matthew A Held; David P Curley; David Dankort; Martin McMahon; Viswanathan Muthusamy; Marcus W Bosenberg
Journal:  Cancer Res       Date:  2010-01-01       Impact factor: 12.701

9.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

10.  Efficient tumour formation by single human melanoma cells.

Authors:  Elsa Quintana; Mark Shackleton; Michael S Sabel; Douglas R Fullen; Timothy M Johnson; Sean J Morrison
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962

View more
  18 in total

Review 1.  A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

Authors:  Nancy Ratner; Shyra J Miller
Journal:  Nat Rev Cancer       Date:  2015-04-16       Impact factor: 60.716

2.  Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model.

Authors:  N Sanchez-Macedo; J Feng; B Faubert; N Chang; A Elia; E J Rushing; K Tsuchihara; D Bungard; S L Berger; R G Jones; T W Mak; K Zaugg
Journal:  Cell Death Differ       Date:  2013-02-15       Impact factor: 15.828

3.  Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer.

Authors:  Joseph S Dosch; Elizabeth K Ziemke; Amrith Shettigar; Alnawaz Rehemtulla; Judith S Sebolt-Leopold
Journal:  Cancer Res       Date:  2015-09-10       Impact factor: 12.701

4.  Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation.

Authors:  Steven D Rhodes; Yongzheng He; Abbi Smith; Li Jiang; Qingbo Lu; Julie Mund; Xiaohong Li; Waylan Bessler; Shaomin Qian; William Dyer; George E Sandusky; Andrew E Horvai; Amy E Armstrong; D Wade Clapp
Journal:  Hum Mol Genet       Date:  2019-08-15       Impact factor: 6.150

5.  Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.

Authors:  Vincent Chau; S Kyun Lim; Wei Mo; Chiachi Liu; Amish J Patel; Renée M McKay; Shuguang Wei; Bruce A Posner; Jef K De Brabander; Noelle S Williams; Luis F Parada; Lu Q Le
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701

6.  Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus.

Authors:  Slawomir Antoszczyk; Melanie Spyra; Victor Felix Mautner; Andreas Kurtz; Anat O Stemmer-Rachamimov; Robert L Martuza; Samuel D Rabkin
Journal:  Neuro Oncol       Date:  2014-01-26       Impact factor: 12.300

Review 7.  Cancer stem cells: impact, heterogeneity, and uncertainty.

Authors:  Jeffrey A Magee; Elena Piskounova; Sean J Morrison
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

8.  The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.

Authors:  Bryan King; Thomas Trimarchi; Linsey Reavie; Luyao Xu; Jasper Mullenders; Panagiotis Ntziachristos; Beatriz Aranda-Orgilles; Arianne Perez-Garcia; Junwei Shi; Christopher Vakoc; Peter Sandy; Steven S Shen; Adolfo Ferrando; Iannis Aifantis
Journal:  Cell       Date:  2013-06-20       Impact factor: 41.582

Review 9.  Tumour heterogeneity and cancer cell plasticity.

Authors:  Corbin E Meacham; Sean J Morrison
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

10.  Mouse models of sarcomas: critical tools in our understanding of the pathobiology.

Authors:  Sean M Post
Journal:  Clin Sarcoma Res       Date:  2012-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.